BH3 Intrinsic Valuation and Fundamental Analysis - PTC Therapeutics Inc

	PTC Therapeutics Inc F:BH3	US
I	Interpublic Group of Companies Inc DUS:IPG	US
A	Amphenol Corp XMUN:XPH	US

Intrinsic Value

The intrinsic value for PTC Therapeutics Inc (BH3) under the Base Case is 56.09 EUR. Compared with the current market price of 58.86 EUR, the stock appears Overvalued by 5% .

Intrinsic value calculated using Multiples

€56.09

Other reference points

DCF valuation

€44.06

Wall St target

€84.11

Do our valuations actually work? See backtest results .

BH3 Intrinsic Value

Overvaluation 5%

Intrinsic Value

Price €58.86

Track Buy Zone

20% below Intrinsic Value €44.87

Get notified when the price drops into your buy zone

Current Price €58.86

Intrinsic Value €56.09

Margin of Safety 20% €44.87

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for PTC Therapeutics Inc.

Explain Valuation